Consenting Process for Radiation Facilities - Atomic Energy ...

The Consentee is required to submit to AERB, the periodic safety status
reports. Unusual occurrences should be promptly reported within 24 hours
and this should be followed by a detailed report within the prescribed period.
The Consentee is also required to report on the availability of qualified and
trained manpower approved by AERB, at all times of operation of the facility,
malfunctioning of radiation monitoring and measuring devices and
malfunctioning of any of the safety systems and emergency systems. IFRT
installations are inspected routinely by AERB and also whenever there is an
unusual incident.
The Consentee shall arrange to constitute a local safety committee(LSC) with
facility-in-charge as Chairman and RSO as Member Secretary, to periodically
review the safety status of the IFRT. The Committee may also include the
operator(s) and service engineer(s) as members. The minutes of the LSC
meetings and action taken reports shall be available for inspection by AERB.
3.4.3.5 Decommissioning/Disposal
When the integrated facility for radiation technology is no longer to be used,
the decommissioning proposal should be submitted to AERB. The facility
has to be checked for presence of any radioactivity, before it can be
decommissioned which may include dismantling and recycling/reuse of
materials. For the above, the consentee should obtain an Authorisation from
AERB for transfer/disposal of radioactive waste to the authorised waste
management agency. The application format for obtaining the said
authorisation for safe disposal of radioactive waste is given in Annexure 50.
The consentee is required to submit a report to AERB on completion of
decommissioning, safe disposal of sources and personnel doses received
during decommissioning operations.
3.4.3.6 Lead Time for Submission/Availability of Documents
The lead time for submission of documents for any stage of Consenting process
is 90 days before the desired date of Consent and documents should be
complete in all respects for review by AERB.
3.5 Telegamma and Accelerator Facilities used in Radiation Therapy
3.5.1 Telegamma Radiation Therapy Facility
3.5.1.1 General
Radiation therapy is beneficial in treating cancers and certain non-malignant
lesions. Deep-seated tumours, not otherwise accessible, are best treated by
external beams of gamma rays or high energy X-rays. Shallow tumours are
treated by high energy electrons or low energy gamma/ X-rays. The aim is to
34